Dec. 27 at 9:10 AM
WATCHLIST DEC 27 2024.
$ASMB Assembly Biosciences Reports Interim Phase 1b Results From Trial Evaluating ABI-4334 In Chronic Hepatitis B; Says ABI-4334 Was Well Tolerated And Showed Mean Reduction Of 2.9 log IU/mL In Plasma HBV DNA Over 28 Days Of Treatment
$COEP Coeptis Therapeutics Acquires NexGenAI Affiliates Network Platform And Launches Coeptis Technologies To Drive AI Innovation In Biotech And Technology, Expanding Growth Potential With Advanced Marketing And Automation Tools
$WULF Northland Capital Markets Maintains Outperform on TeraWulf, Maintains
$10 Price Target
$BRX Evercore ISI Group Maintains In-Line on Brixmor Property Group, Lowers Price Target to
$31
$NNE NANO Nuclear Energy Enters Into Agreement To Acquire Ultra Safe Nuclear Corp.'s Patented Micro Modular Reactor MMR And Pylon Space Reactors For
$8.5M Along With Worldwide Demonstration Partnerships